## LVS: Las Vegas Sands Corp. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.89 indicates fundamental undervaluation. Quality metrics strong (ROE 66%). Consistent execution (3/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($63.85)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 6, Bearish: 0)

**1. The Bull Case For Las Vegas Sands (LVS) Could Change Following CEO Stock Sale And Goldman Sachs Upgrade**
- Source: Simply Wall Street | 20251216T195758 | Somewhat-Bullish | Relevance: 100%
- Las Vegas Sands (LVS) recently saw its CEO sell $26.6 million in stock after exercising options, while Goldman Sachs upgraded the company to "Buy" with an $80 price target. This upgrade signals confidence in LVS's Singapore and Macau operations, reinforcing the importance of these regions' performance for the stock. Despite the insider selling, the core investment narrative remains tied to the long-term earnings power of its resorts in these key Asian markets.

**2. Las Vegas Sands (NYSE: LVS) shareholder files notice for 1.5M-share Rule 144 sale**
- Source: Stock Titan | 20251215T230903 | Neutral | Relevance: 100%
- A Las Vegas Sands (NYSE: LVS) shareholder, Robert G. Goldstein, has filed a Rule 144 notice to sell 1.5 million shares of common stock through Goldman Sachs & Co. LLC. The proposed sale has an aggregate market value of $100,485,000. These shares were acquired as compensation via stock options on December 15, 2025, using a cashless exercise and same-day sale structure, with previous sales by Goldstein also noted.

**3. Las Vegas Sands stock rating upgraded to Buy at Goldman Sachs**
- Source: Investing.com | 20251215T100837 | Bullish | Relevance: 100%
- Goldman Sachs upgraded Las Vegas Sands (NYSE:LVS) to Buy from Neutral, setting an $80 price target due to expected sustained momentum in Macau gaming revenue and strong performance at Marina Bay Sands. The firm expects Las Vegas Sands to maintain high EBITDA, engage in significant share repurchases, and invest in its IR2 project. This upgrade aligns with recent positive analyst updates following the company's stronger-than-expected third-quarter performance.

**4. Robert Goldstein Sells 734,511 Shares of Las Vegas Sands (NYSE:LVS) Stock**
- Source: MarketBeat | 20251216T230446 | Neutral | Relevance: 100%
- Robert Goldstein, CEO of Las Vegas Sands (NYSE:LVS), sold 734,511 shares of the company's stock for approximately $49.07 million. This insider transaction comes as LVS posted stronger-than-expected Q3 earnings and revenue, leading analysts to raise price targets and maintain "buy" ratings for the stock, which is trading near its 52-week high with a 1.5% dividend yield.

**5. Las Vegas Sands Rating, Price Target Lifted by Goldman Sachs**
- Source: Casino.org | 20251216T180238 | Bullish | Relevance: 100%
- Goldman Sachs has upgraded Las Vegas Sands (NYSE: LVS) to “buy” from “hold,” increasing its price target to $80 from $64 due to strong performance at Marina Bay Sands in Singapore and an anticipated $2 billion share buyback program. The analyst, Lizzie Dove, also maintains a “buy” rating on Wynn Resorts (NASDAQ: WYNN), citing its high-end assets and improving Macau market conditions.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Goldman Sachs | $80 | $64 | +25% |
| 2025-12-08 | UBS | $68 | $67 | +1% |
| 2025-12-01 | Argus Research | $80 | $65 | +23% |
| 2025-11-18 | Wells Fargo | $66 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Goldman Sachs | up | Buy |
| 2025-12-08 | UBS | main | Neutral |
| 2025-12-01 | Argus Research | main | Buy |
| 2025-11-18 | Wells Fargo | init | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 8 ($37.55M) |
| Sells | 8 ($47.01M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.9% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 6.2% (-2.0%)
- Capital Research Glo: 5.0% (-30.9%)
- Blackrock Inc.: 4.0% (-0.1%)
- Price (T.Rowe) Assoc: 2.2% (-7.8%)
- State Street Corpora: 2.1% (-7.2%)

### Key Risks

1. Heavy insider selling: $47M sold (8 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +17%) could attract flows.
- Momentum building: MRS_20 improving +3.6% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 0.89 indicates undervaluation relative to growth. Forward P/E 21.2x stretched relative to 9% growth. Quality metrics strong (ROE 66%). Analyst sentiment positive (3 raises, avg +17%). Institutional flow bearish (8 selling vs 2 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $46.2B |
| Beta | 0.97 |
| 52W Range | $30.18 - $70.45 |
| Short Interest | 2.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.89 |
| Forward P/E | 21.2 |
| Current P/E | 23.2 |
| YoY Growth | 9.4% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from -2.2% to 1.4% (+3.6% in 5 days), confirming momentum buildup. Below STRENGTH zone by 2.6pp (needs >4.0% for momentum thesis). MRS_5 at 2.2% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). Elevated volume (1.5x 20MA), institutional activity likely. OFD pattern: +SUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.37% (CS: 54) | Neutral |
| RSI_14 | 60.1 | Neutral |
| MACD Histogram | -0.43 | Bearish |
| vs SMA20 | 1.013x | Above |
| vs SMA50 | 1.105x | Above |
| vs SMA200 | 1.361x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $67.31
- **Stop Loss:** $63.85 (5.1% risk)
- **Target:** $74.23 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 346
- **Position Value:** $23,289.26
- **Portfolio %:** 23.29%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with balanced risk positioning. VIX remains calm at 16.48 while breadth shows modest improvement to 52%, indicating neither euphoria nor distress. Mixed sectoral themes from energy weakness to AI expansion suggest stock-picking environment rather than broad directional moves.*

### Earnings

**Next:** 2026-01-28 (Est: $0.75)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.62 | $0.78 | +25.4% |
| 2025Q2 | $0.53 | $0.79 | +48.9% |
| 2025Q1 | $0.57 | $0.59 | +3.8% |
| 2024Q4 | $0.58 | $0.54 | -6.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*